BeyondSpring Inc. Income (Loss) from Continuing Operations, Per Diluted Share
BeyondSpring Inc. (BYSI) reported Income (Loss) from Continuing Operations, Per Diluted Share of -$0.02 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare · last filed 2026-08-14
- BeyondSpring Inc. income (loss) from continuing operations, per diluted share for the quarter ending 2026-06-30 was -$0.02.
- BeyondSpring Inc. income (loss) from continuing operations, per diluted share for the quarter ending 2025-06-30 was -$0.04.
- BeyondSpring Inc. income (loss) from continuing operations, per diluted share for the quarter ending 2024-06-30 was -$0.04.
| Period end | Income (Loss) from Continuing Operations, Per Diluted Share 3 month | Income (Loss) from Continuing Operations, Per Diluted Share 3 month as first filed | Income (Loss) from Continuing Operations, Per Diluted Share 6 month | Income (Loss) from Continuing Operations, Per Diluted Share 6 month as first filed |
|---|---|---|---|---|
| 2026-06-30 | -$0.02 10-Q · filed 2026-08-14 | -$0.08 10-Q · filed 2026-08-14 | ||
| 2025-06-30 | -$0.04 10-Q · filed 2026-08-14 | -$0.07 10-Q · filed 2025-08-13 | -$0.11 10-Q · filed 2026-08-14 | -$0.12 10-Q · filed 2025-08-13 |
| 2024-06-30 | -$0.04 10-Q · filed 2025-08-13 | -$0.11 10-Q · filed 2025-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |